Tellgen

Tellgen, officially Shanghai Toukang Life Technology Co., Ltd., is a China-based entity operating in the Medical Devices & Equipment and Manufacturing sectors. Founded in 2003, the company focuses on the research, development, production, and sales of in vitro diagnostic (IVD) products. Its core offerings encompass a broad spectrum of diagnostic reagents and instruments designed for critical healthcare applications, serving a global market.

The company provides advanced solutions for tumor markers, autoimmune diseases, reproductive health, and molecular diagnostics, serving healthcare providers, laboratories, and research institutions. With a workforce of 500-1,000 employees, Tellgen generated revenue of $70.6M. Their operational scope includes innovative product development and adherence to international standards, reflecting a commitment to quality and efficacy in the IVD market. Meet Tellgen's team to understand the leadership driving these advancements.

Leveraging over 18 years of experience, Tellgen has established itself as a recognized provider of diagnostic solutions. The company's strategic focus on R&D and production ensures a pipeline of innovative IVD products. While the provided data indicates zero physical locations beyond headquarters, the company's reach is implied through its product sales to a wide client base. Hashtags suggest a focus on B2B operations, public market presence, and its geographical positioning within Asia.